pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›HYRIMOZ
drug
save

HYRIMOZ

Marketedupdated 5mo ago
by Sandoz Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 4
  • tagApproval52 co-mentions · 13 sources
  • companySandoz Inc26 co-mentions · 13 sources
  • drugHUMIRA26 co-mentions · 13 sources
  • drugadalimumab26 co-mentions · 13 sources

all catalysts(13)

approval · 13
Oct 30, 2018
approval
8y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Feb 24, 2021
approval
6y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Mar 28, 2022
approval
5y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Jul 18, 2022
approval
4y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Jul 18, 2022
approval
4y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Mar 20, 2023
approval
4y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Apr 14, 2023
approval
3y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Sep 8, 2023
approval
3y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Apr 5, 2024
approval
2y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Jun 12, 2024
approval
2y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
May 20, 2025
approval
1y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Jul 29, 2025
approval
1y ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
Oct 16, 2025
approval
12mo ago
HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
HYRIMOZ
→
view all 13 catalysts →

Trials studying HYRIMOZ

  • —Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Settingactive not recruitingn=562

News(0)

no news has mentioned this drug yet

brand
HYRIMOZ
generic
ADALIMUMAB-ADAZ
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 2h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?